Cancer of the Cervix
12
1
3
4
Key Insights
Highlights
Success Rate
80% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 39/100
8.3%
1 terminated out of 12 trials
80.0%
-6.5% vs benchmark
25%
3 trials in Phase 3/4
50%
2 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (12)
Compass - Randomised Controlled Trial of Primary HPV Testing for Cervical Screening in Australia
Glutaminase Inhibition and Chemoradiation in Advanced Cervical Cancer
Intratreatment FDG-PET During Radiation Therapy for Gynecologic and Gastrointestinal Cancers
MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial
Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation
Predicting Adjuvant Post-operative Radiation Therapy in Patients With Cervical Cancer Stage IB2
Integrated Dose Escalation for Advanced, Localized Gynecologic Cancer (The IDEAL - GYN Trial)
Ultrasound and Photoacoustic Imaging for Cervical Cancer
A Phase I/II Study of Cisplatin and Radiation in Combination With Sorafenib in Cervical Cancer
High Dose Rate (HDR) Versus Low Dose Rate (LDR) Brachytherapy in Carcinoma Cervix
Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients
Cetuximab, Cisplatin, and Radiotherapy in Women With Locally Advanced Cervical Carcinoma